Artist’s rendering of brain fog: a bright blue drawing of a brain sits inside of a pink drawing of a head in profile surrounded by miscellaneous shapes
Brain Fog Caused by Long COVID and Chemo Appear Similar
Data from mouse models for mild coronavirus infections and human tissue samples offer further evidence that it doesn’t take a severe infection—or even infection of brain cells at all—to cause long-term neurological symptoms.
ABOVE: © ISTOCK.COM, DRAFTER123
Brain Fog Caused by Long COVID and Chemo Appear Similar
Brain Fog Caused by Long COVID and Chemo Appear Similar

Data from mouse models for mild coronavirus infections and human tissue samples offer further evidence that it doesn’t take a severe infection—or even infection of brain cells at all—to cause long-term neurological symptoms.

Data from mouse models for mild coronavirus infections and human tissue samples offer further evidence that it doesn’t take a severe infection—or even infection of brain cells at all—to cause long-term neurological symptoms.

ABOVE: © ISTOCK.COM, DRAFTER123
  1. Home
  2. Subjects
  3. chemotherapy

chemotherapy

grey and purple cancer cells under a microscope
Cell Diversity Could Spell Trouble for Animal Models of Cancer
David Adam | Nov 19, 2021
Tracking human cancers in mice shows some unexpected cell changes that could undermine translational research.  
neutrobots, neutrophils, white blood cells, microrobots, nanorobots, microbots, glioma, brain cancer, paclitaxel, magnetic, swarm, mice
Microscopic Robots Deliver Drugs to the Brain
Asher Jones | Mar 30, 2021
Researchers turned white blood cells called neutrophils into drug-smuggling “neutrobots,” which penetrated the blood-brain barrier to treat brain cancer in mice.
Linking Biological Clocks and Cancer Therapeutics to Minimize Toxicity
It’s All in the Timing: Optimizing Chemotherapy Administration
Sejal Davla, PhD | Mar 1, 2022
How the biological clock influences chemotherapy success
Gloria Echeverria Investigates an Insidious Form of Breast Cancer
Max Kozlov | Dec 1, 2020
The newly minted Baylor College of Medicine faculty member is working to crack the mystery of triple negative breast cancer.
Baby Born from Egg that Was Matured and Frozen in the Lab
Catherine Offord | Feb 19, 2020
A cancer patient who underwent the new fertility preservation procedure successfully gave birth five years after her immature eggs were collected.
800x800
A 3-D Tumor Microenvironment for Personalized Immunotherapy
Roni Dengler, PhD | Sep 10, 2021
A new platform enables screening a wide range of combination anticancer therapeutics in a matter of days, which may translate to personalized therapeutic regimens for patients in less time.
Image of the Day: Patient-Derived Organoids
Emily Makowski | Oct 10, 2019
Three-dimensional tissue cultures grown from cancer patients’ own tumors can predict responses to the drug irinotecan.
removing chemotheraphy drugs
Mopping Up Excess Chemotherapy Drugs
Ruth Williams | Apr 1, 2019
A prototype in-vein device would collect toxic medications before they reach healthy tissues.
Mammary tumor organoids undergo a radical shape shift when treated with a microRNA.
Organoid Shape Identifies Potential Cancer Drugs
Roni Dengler, PhD | Aug 3, 2021
An unusual drug screen takes advantage of “porcupine-like” structures of cancer cells in 3D organoids.
removing chemotherapy drugs infographic
Infographic: Medication Mop-Up
Ruth Williams | Apr 1, 2019
Researchers have developed a prototype device to filter excess chemotherapy medication from the bloodstream.
From Chemical Weapon to Chemotherapy, 1917–1946
Carolyn Wilke | Apr 1, 2019
Mustard gas blistered men’s bodies on the battlefield, but paved the way for cancer-fighting drugs.
Cancer Vaccines: Raising a T Cell Army
Niki Spahich, PhD | Apr 1, 2021
Vaccines against various forms of cancer prime the immune system to attack.
Exosomes Linked to Cancer Spread from Chemoresistant Tumors in Mice
Carolyn Wilke | Jan 10, 2019
The vesicles promote metastasis after chemotherapy, but the authors say the results shouldn’t alarm patients and may point to ways to improve treatments.
Leukemia Relapses May Arise From Specialized Cells
Sukanya Charuchandra | Dec 1, 2018
Targeting the transient group of cells could prevent recurrence of the disease.
Surveillance Gaps: How Cancer Arises
The Scientist Creative Services Team | Mar 15, 2021
Surveillance Gaps: How Cancer Arises
Drug Cocktail Slows Progress of Aggressive Breast Cancer
Ashley P. Taylor | Oct 22, 2018
Checkpoint inhibition combined with chemotherapy gives patients with triple-negative metastatic breast cancer about two months more time without significant tumor growth, a study finds.
Mutant RAS Proteins Team Up for Oncogenicity
Jim Daley | Apr 1, 2018
Mice with cancer whose KRAS proteins couldn’t link together had much better survival outcomes than those whose oncogenic mutant paired with wild-type KRAS.
A Radical Intervention, 1894
Catherine Offord | Apr 1, 2018
William Halsted’s approach to mastectomy took the medical world by storm at the turn of the last century.
Researchers Getting Smarter About Pairing Cancer Treatments
Anna Azvolinsky | Apr 1, 2018
Multidrug combinations lead to better results for cancer patients, but efficiently identifying them is proving difficult.